Skip Navigation

Biostatistics Research Branch (BRB)

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Claire W. Hallahan Publications

Migueles SA, Osborne CM, Royce C, Compton AA, Joshi RP, Weeks KA, Rood JE, Berkley AM, Sacha JB, Cogliano-Shutta NA, Lloyd M, Roby G, Kwan R, McLaughlin M, Stallings S, Rehm C, O'Shea MA, Mican J, Packard BZ, Komoriya A, Palmer S, Wiegand AP, Maldarelli F, Coffin JM, Mellors JW, Hallahan CW, Follman DA, Connors M. Lytic Granule Loading of CD8(+) T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune Control. Immunity. In press Dec 2008

Doria-Rose NA, Klein RM, Manion MM, O'Dell S, Phogat A, Chakrabarti B, Hallahan CW, Migueles SA, Wrammert J, Ahmed R, Nason M, Wyatt RT, Mascola JR, Connors M.Frequency and Phenotype of HIV Envelope-specific B Cells From Patients With Broadly Cross-Neutralizing Antibodies. J Virol. In press Dec 2008

Chun TW, Nickle DC, Justement JS, Meyers JH, Roby G, Hallahan CW, Kottilil S, Moir S, Mican JM, Mullins JI, Ward DJ, Kovacs JA, Mannon PJ, Fauci AS. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J Infect Dis. Vol 197: (5) 714-20, 2008

Tilton JC, Manion MM, Luskin MR, Johnson AJ, Patamawenu AA, Hallahan CW, Cogliano-Shutta NA, Mican JM, Davey RT Jr, Kottilil S, Lifson JD, Metcalf JA, Lempicki RA, Connors M. Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro. J Virol. Vol 82: (8) P3997-4006, 2008

Kottilil S, Jackson JO, Reitano KN, O’Shea MA, Roby G, Lloyd M, Yang J, Hallahan CW, Rehm CA, Arthos J, Lempicki R, Fauci AS. Innate immunity in HIV infection – Enhanced susceptibility to CD9S-mediated natural killer cell death and turnover induced by HIV viremia. JAIDS-Journal of Acquired Immune Deficiency Syndrome. Vol 46: (2) 151-159, 2007

Chun TW, Justement JS, Moir S, Hallahan CW, Maenza J, Mullins JI, Collier AC, Corey L, Fauci AS. Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: Implications for eradication of virus. J Infect Dis. Vol 195: (12) 1762-1764, 2007

Tilton JC, Luskin MR, Johnson AJ, Manion M, Hallahan CW, Metcalf JA, McLaughlin M, Davey RT, Connors M. Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4(+) T cells are a consequence of antigen load. J Virol. Vol 81: (6) 2713-2725, 2007

Tilton JC, Johnson AJ, Luskin MR, Manion MM, Yang J, Adelsberger JW, Lempicki RA, Hallahan CW, McLaughlin M, Mican JM, Metcalf JA, Ivasere C, Connors M. Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons. J Virol. Vol 80: (23) 11486-11497, 2006

Keh CE, Shen JM, Hahn B, Hallahan CW, Rehm CA, Davey RT, Lane HC, Sereti I. Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-Cell responses to interleukin-2 administration in HIV infected patients. AIDS. Vol 20: (3) P361-369, 2006

Kottilil S, Shin K, Jackson JO, Reitano KN, O’Shea MA, Yang J, Hallahan CW, Lempicki R, Arthos J, Fauci AS. Innate immune dysfunction in HIV infection: Effect of HIV envelope-NK cell interactions. Journal of Immunology. Vol 176: (2) 1107-1114, 2006

Chun TW, Nickle DC, Justement JS, Large D, Semerjian A, Curlin ME, O’Shea MA, Hallahan CW, Daucher M, Ward DJ, Moir S, Mullins JI, Kovacs C, Fauci AS. HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. J Clin Invest. Vol 115: (11) 3250-3255, 2005

Sereti I, Anthon KB, Martinez-Wilson H, Lempicki R, Adelsberger J, Metcalf JA, Hallahan, CW, Davey RT, Kovacs JA, Lane HC. IL2-Induced CD4+ T cell expansion in HIV-infected patients is associated with decreased T cell proliferation. Blood Journal. Vol 104: (3) 775-780, 2004

Dybul M, Nies-Kraske E, Dewar R, Maldarelli F, Hallahan, CW, Daucher M, Piscitelli SC, Ehler L, Weigan A, Palmer S, Metcalf JA, Davey RT, Kress DMR, Powers A, Beck I, Frenkel L, Baseler M, Coffin J, Fauci AS. A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for treatment of chronic HIV infection. J Infect Dis. Vol 189 (11) 1974-1982, 2004

Kottilill S, Shin K, Planta M, McLaughlin M, Hallahan CW, Ghany M, Chun TW, Sneller MC, Fauci AS. Expression of chemokine and inhibitory receptors on natural killer cells: Effect of immune activation and HIV viremia. J Infect Dis. 189 (7) 1193-1198, 2004.

Chun TW, Justement JS, Sanford C, Hallahan CW, Planta MA, Loutfy M, Kottilil S, Moir S, Kovacs C, Fauci AS. Relationship between the frequency of HIV-specific CD8(+) T cells and the level of CD38(+)CD8(+) T cells in untreated HIV-infected individuals. Proc Natl Acad Sci. 101 (8): 2464-2469, 2004

Iyasere C, Tilton JC, Johnson AJ, Younes S, Yassine-Diab B, Sekaly RP, Kwok WW, Migueles SA, Laborico AC, Shupert WL, Hallahan, CW, Davy RT, Dybul M, Vogel S, Metcalf J, Connors M. Diminished proliferation of human immunodeficiency virus-specific CD4(+) T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J Virol. Vol 77: (20) 10900-10909, 2003.

Dybul M, Nies-Kraske E, Daucher M, Hertogs K, Hallahan, CW, Csako G, Yoder C, Ehler L, Sklar PA, Belson M, Hildaldo B, Metcalf JA, Davy RT, Dress DMR, Powers A, Fauci AS. Long-cycle structured intermittent versus continuous highly active antiretroviral therapy for the treatment of chronic infection with human immunodeficiency virus: Effects on drug toxicity and on immunologic and virologic parameters. J Infect Dis. Vol 188 (3): 388-396, 2003.

Malaspina, A., Moir, S., Kottilil, S., Hallahan, C.W., Ehler, L.A., Liu, S.Y., Planta, M.A., Chun, T.W., Fauci, A.S. Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function. J Immunol. 170: (12) 5965-5972, 2003.

Migueles S.A., Laborico A.C., Imamichi, H., Shupert, W.L., Royce, C., McLaughlin, M., Ehler, L., Metcalf, J., Liu, S.Y., Hallahan, C.W., Connors, M. The differential ability of HLA b*5701(+) long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences. J Virol. Vol 77: (12) 6889-6898, 2003

Moir, S., Ogwaro, K.M., Malaspina, A., Vasquez, J., Donoghue, E.T., Hallahan, C.W., Liu, S., Ehler, L.A., Planta, M.A., Kottilil, S., Chun, T.W., Fauci, A.S. Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals. Proc Natl Acad Sci. 100: (10) 6057-6062, 2003.

Dybul, M., Daucher, M. Jensen, M.A., Hallahan, C.W., Chun, T.W., Belson, M., Hidalgo, B., Nickle, D.C., Yoder, C., Metcalf, J.A., Davey, R.T., Ehler, L., Kress-Rock, D., Nies-Kiraske, E., Liu, S., Mullens, J.I., Fauci, A.S. Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy. J Virol. 77 (5): 3229-3237, 2003.

Kottilil, S., Chun, T.W., Moir, S., Liu, S., McLaughlin, N., Hallahan, C.W., Maldarelli, F., Corey, L, Fauci, A.S. Innate immunity in human immunodeficiency virus infection: Effect of viremia on natural killer cell function. J Infect Dis. Vol 187(7): 1038-1045, 2003.

Miqueles, S.A., Laborico, A.C., Shupert, W.L., Sabbaghian, M.S., Rabin, R., Hallahan, C.W., Van Baarle, D., Kostense S., Miedema, F., McLaughlin, M., Ehler, L., Metcalf J., Liu, S.Y., Connors, M. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nature Immunol. Vol 3 (11): 1061-1068, 2002.

Chun, T.W., Justement, J.S., Lempicki, R.A., Yang, J., Pandya, P., Hallahan, C.W., Liu, S., McLaughlin, M., Ehler, L.A., Moir, S., Fauci, A.S. Gene expression and viral production in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals. Pro Natl Acad Sci. Vol 100 (4): 1908-1913, 2002.

Chun, T.W., Justement, J.S., Pandya, P., Hallahan, C.W., McLaughlin, M., Liu, S., Ehler, L.A., Kovacs, C., Fauci, A.S. Relationship between the size of the human immunodeficiency virus type1 (HIV-1) reservoir in peripheral blood CD4(+) T cells and CD4(+): CD8(+) T cell ratios in aviremic HIV-1-infected individuals receiving long-term highly active antiretroviral therapy. J Infect Dis. Vol 185: (11) 1672-1676, 2002.

Dybul, M., Bolan, R., Condoluci, D., Cox-Iyamu, R., Redfield, B., Hallahan, C.W., Folino, M., Sathasivam, K., Weisberg, M., Andrews M., Hidalgo, B., Vasquez, J., Fauci, A.S. Evaluation of the initial CD4+ T cell counts in individuals with newly diagnosed HIV infections, by sex and race, in urban settings. J Infect Dis. Vol 185: (12) 1818-1821, 2002.

Sereti, I., Martinez-Wilson, H., Metcalf, J.A., Baseler, M.W., Hallahan, C.W., Hengel, R., Kovacs, J., Lane, H.C. Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: Characterization of a novel subset of CD4+/CD25+ T cells. Blood. Vol 100 (6) 2159-2167, 2002.

Dybul, M., Hidalgo, B., Chun, TW., Belson, M., Migueles, Stephen A., Justement, J.S., Harpin, B, Perry, C, Hallahan, C.W., Davey, R.T., Metcalf, J.A., Connors, M., Fauci, A.S. Pilot study of effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection. J Infect Dis. Vol 185: (1) 61-68. 2002.

Bernstein, H., Kinter, A., Chun, T.W., Jackson, R., Hallahan, C., Fauci, A., The effect of elective c-section, preterm labor and chorioamnionitis on fetal lymphocyte activation and susceptibility to HIV infection. Am J Obstetrics Gynecology. Vol 185: (6) 395 Suppl. 2001.

Dybul, M., Chun, TW, Yoder, C, Hidalgo, B., Belson, M., Hertogs, K., Larder, B., Dewar, R.L., Fox, C.H., Hallahan, C.W., Justement, J.S., Migueles, S., Metcalf, J.A., Davey, R.T., Daucher, M., Pandya, P., Baseler, M., Ward, D.J., Fauci, A.S. Short cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic and toxicity parameters. Proc Natl Acad Sci. Vol 98: (26) 15161-15166, 2001.

Sereti, I., Herpin, B., Metcalf, J.A., Stevens, R., Baseler, M.W., Hallahan, C.W., Kovacs, J.A., Davey, R.T. Lane, H.C. CD4 T cell expansions are associated with increased apoptosis rates of T lymphocytes during intermittent IL-2 administration in HIV infected patients. AIDS. Vol 15: (14) 1765-1775, 2001.

McNeil, A.C., Shupert, W.L., Iyasere, C.A., Hallahan, C.W., Mican, JA, Davey, R.T., Connors, M. High level HIV-1 viremia suppresses viral antigen-specific CD4+ T cell proliferation. Proc Natl Acad Sci. Vol 98: (24) 13878-13883, 2001.

Straus, S.E,. Jaffe, E.S., Puck, J.M., Dale, J.K., Elkon, K.B., Rosen-Wolff, A., Peters, A.M.J., Sneller, M.C., Hallahan, C.W., Wang, J., Fischer, R.E., Jackson, C.M., Lin, A.Y., Baumler, C., Siegert, E., Marx, A., Vaishnaw, A.K.,Grodzicky, T., Fleisher, T.A., Lenardo, M.J. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood. Vol 98: (1) 194-200, 2001.

Chun, Tae-Wook, Justement, J.S, Moir, S., Hallahan, C.W., Ehler, L.A. Liu, S., McLaughlin, M., Dybul, M., Mican, J.M., Fauci, A.S. Suppression of human immunodeficiency virus replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: Implication for the development of therapeutic Strategies. Proc Natl Acad Sci. Vol 98: (1) 253-258, 2000.

Gea-Banacloche, J.C., Migueles, SA, Martino. L, Shupert, W.L., McNeil, A.C., Sabbaghian, M.S., Ehler, L, Prussin, C., Stevens, R., Lambert, L., Altman, J., Hallahan, C.W., Lopez bernaldo de Quiros, J. C., Connors, M. Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors. J Immunol. Vol 165: (2) 1082-1092, 2000.

Gea-Banacloche, J.C., Martino, L., Mican, J.M., Hallahan, C.W., Baseler, M., Stevens, R., Lambert, L., Polis, M., R., Lane, H.C., Connors, M. Longitudinal changes in CD4+T cell antigen receptor diversity and naive/memory cell phenotype during 9 to26 months of antiretroviral therapy of HIV- infected patients. AIDS Research and Human Retroviruses. Vol 16:(17) 1877-1886, 2000.

Migueles, S.A., Sabbaghian, M.S., Shupert, W.L., Bettinotti, M.P., Marincola, F.M., Martino, L., Hallahan, C.W., Selig, S.M. Schwartz, D., Sullivan, J., Connors, M. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long-term nonprogressors. Proc Natl Acad Sci. Vol 97: (6) 2709-2714, 2000.

Sereti, I., Gea-Banacloche, J.C., Kan, M., Hallahan, C.W., Lane, H.C. Interleukin 2 leads to dose-dependent expression of the alpha chain of the IL-2 receptor on CD25 negative T lymphocytes in the absence of exogenous antigenic stimulation. Clin Immunol. Vol 93: (3) 226-276, 2000

Dybul, M., Mercier, G., Belson, M., Hallahan, C.W., Liu, S., Perry, C., Herpin, B., Ehler, L., Davey, R.T., Metcalf, J., Mican, J.M., Seder, R.A., Fauci, A.S. CD40 ligand trimer and IL-12 enhance periferal blood mononuclear cells and CD4+ T-cell proliferation and production of IFN-gamma in response to p24 antigen in HIV infected individuals: Potential contribution of anergy to HIV-specific unresponsiveness. J Immunol. Vol 165: (3) 1687-1691, 2000

Bernaldo de Quiros, J, Shupert, W.L., McNeil, A.C., Gea-Banacloche, J.C., Flanigan, M, Savage, A, Martino, L, Weiskopf, E.E., Imamichi, H., Zhang, Y., Adelsburger, J., Stevens, R., Murphy, P.M., Zimmerman, P.A., Hallahan, C.W., Davey, R.T., Connor, M., Resistance to replication of human immunodeficiency virus challenge in SCID-Hu mice engrafted with peripheral blood mononuclear cells of nonprogressors is mediated by CD8+ T cells and associated with a proliferative response to p24 antigen. J Virol. Vol 74: (2), 2023-2028, 2000

Ostrowski, M.A., Chun T.W., Justement, S.J., Motola, I., Spinelli, M.A., Adelsberger, J., Ehler, L.A., Mizell, S.B., Hallahan, C.W., Fauci, A.S. Both Memory and CD45RA+/CD62L+ Naive CD4+ T Cells are infected in human immunodeficiency virus type 1- Infected Individuals. J Virol. Vol 73: (8) 6430-6435, 1999.

Jaffe, E.S., Puck, J.M., Jackson, C.E., Dale, J.K., Sneller, M.C., Fischer, R.E., Hsu AP, Hallahan, C.W., Lenardo, M.J.,Straus, S.E. Increased risk for diverse lymphomas in autoimmune lymphoproliferative syndrome (ALPS), an inherited disorder due to defective lymphocyte apoptosis. Blood. Vol 94: (10) 2660, Part1, Suppl. 1 Nov 15, 1999.

Chun, Tae-Wook, Engel, D., Mizell, S.B., Hallahan, C.W.,Davey, R.T.Jr., Dybul, M., Kovacs, J.A., Metcalf, J.A., Mican, J.M.., Lane, H.C.,Fauci, A.S., Effect of Interleukin-2 on the Pool of Latently Infected, Resting CD4+ T Cells in HIV-1 Infected Patients Receiving Highly Active Antiretroviral Therapy. Nature Med. Vol 5:(6) 651-655, 1999.

Ostrowski, M.A., Justement, S.J., Catanzaro, Hallahan, CA, Ehler, L.A., Mizell, S.B. Kumar, P. N. Mican, J.A. , Fauci, A.S., Expression of chemokine receptors CXCR4 and CCR5 in HIV-1 Infected and Uninfected Individuals. J Immunol. Vol 161:(6) 3195-3201, 1998.

Gea-Banacloche, J.C., Weiskopf, E.E., Hallahan, C.W., Lopez bernaldo de Quiros, J. C., Flanigan, M.. Falloon, J., Mican, JM., Baseler, M., Stevens, R., Lane, H.C., Connors, M. Progression of Human Immunodeficiency Virus Disease Is Associated with Increasing Disruptions within the CD4+ T Cell Receptor Repertoire. J Infect Dis. Vol 177: 579-85, 1998.

Taylor-Williams, C., Hijazi, Y.M., Walther, M.M., Linehan, W.M., Hallahan, C.W., Lubensky, I., Kerr, G.S., Hoffman, G.S., Fauci, A.S., Sneller, M.C. Cyclophosphamide-Induced Cystitis and Bladder Cancer in Patients with Wegener Granulomatosis. Ann Internal Med. Vol. 124, No. 5: 477-484, 1996.

Langford, C.A., Sneller, M.C., Hallahan, C.W., Hoffman, G.S., Kammerer, W.A., Taylor-Williams, C., Fauci, A.S., Lebovics, R.S. Clinical Features and Therapeutic Management of Subglottic Stenosis in Patients with Wegener=s Granulomatosis. Arthritis & Rheumatism. Vol. 39, No. 10:1754-1760, 1995.

Sneller M.S., Hoffman G.S., Talar-williams C., Hallahan C.W., Fauci A.S. An Analysis of 42 Wegener=s Granulomatosis Patients Treated with Methotrexate and Prednisone. Arthritis and Rheumatism. 38(5): 608-613, 1995.

Dvorak, J.A., Kobayashi, S, Alling, D.W., Hallahan, C.W. Elucidation of the DNA Synthetic Cycle of Entamoeba Spp. Using Flow Cytometry and Mathematical Modeling. J Eukaryotic Microbiol. 42(5), 610-616, 1995.

Barksdale, S.K., Hallahan, C.W., Kerr, G.S., Fauci, A.S., Stern, J.B., Travis, W.D. Cutaneous Pathology in Wegener's Granulomatosis (A clinico-pathologic study of 75 biopsies in 46 patients). Am J Surgical Pathology. 19(2): 161-172, 1995.

Kerr, G.S., Hallahan, C.W., Giordano, J., Leavitt, R.Y., Fauci, A.S., Rottem, M., Hoffman, G.S. Takayasu Arteritis. Ann Internal Med. 120, No. 11:919-929,1994.

Kerr, G.S., Fleisher, T.A., Hallahan, C.W., Leavitt, R.Y., Fauci, A.S., Hoffman, G.S. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's Granulomatosis. Arthritis & Rheumatism. Vol.36 No.3: 365-371, 1993.

Rottem, M., Fauci, A.S., Hallahan, C.W., Kerr, G.S., Lebovics, R., Leavitt, R.Y., Hoffman, G.S. Wegener granulomatosis in children and adolescents: Clinical presentation and outcome. J Pediatrics. 122:26-31,1993.

Lebovics, R.S., Hoffman, G.S., Leavitt, R.Y., Kerr, G.S., Travis, W.D., Kammerer, W., Hallahan, C., Rottem, Menachem, Fauci, A.S. The management of subglottic stenosis in patients with Wegener's Granulomatosis. Laryngoscope. 102:1341-1345, 1992.

Hoffman, G.S., Kerr, G.S., Leavitt, R.Y., Hallahan, C.W., Lebovics, R.S., Travis, W.D., Rottem, M., Fauci, A.S. Wegener Granulomatosis: An Analysis of 158 Patients. Ann Internal Med. 116: No. 6:488-498, 1992.

Straus, S.E., Seidlin, M., Takiff, H.E., Rooney, J., Felser, J., Smith, H., Roane, P., Johnson, F., Hallahan, C., Ostrove, J., Nusinoff-Lehrman, S. Effect of oral acyclovir treatment on symptomatic and asymptomatic virus shedding in recurrent genital herpes. Sexually Transmitted Diseases. 16:107-113, 1989.

Straus, S.E., Dale, J., Tobi, M., Lawley, T., Preble, O., Blaese, M., Hallahan, C., and Henle, W. Acyclovir treatment of the chronic fatigue syndrome - lack of efficacy in a placebo-controlled trial. N Engl J Med. 319:1692-1698, 1988.

Straus, S.E., Croen, K.D., Sawyer, M., Freifeld, A.G., Felser, J., Dale, J., Smith, H.A., Hallahan, C., and Nusinoff-Lehrman, S. Acyclovir suppression of frequently recurring genital herpes: efficacy and diminishing need during successive years of treatment. J Amer Med Assoc. 260:2227-2230, 1988.

Hoofnagle, J.H., Peters, M., Mullen, K., Jones, D.B., Rustgi, V., Di Bisceglie, A., Hallahan, C., Park, Y., Meschievitz, C., and Jones, E.A. Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B. Gastroenterology. 95:1318-1325, 1988.

Straus, S.E., Seidlin, M., Takiff, H.E., Rooney, J.F., Nusinoff-Lehrman, S.N., Bachrach, S., Felser, J., DiGiovanna, J.J., Grimes, G.J., Jr., Krakauer, H., Hallahan, C., and Alling, D. Double-blind comparison of weekend and daily regimens of oral acyclovir for suppression of recurrent genital herpes. Antiviral Research. 6:151-159, 1986.

Weetman, A.P., Ratanachaiyavong, S., Love, W., Middleton, G.W., John, R., Hallahan, C., Alling, D., Lazarus, J.H., Hall, R., and McGregor, A.M. Outcome after Carbimazole (CBZ) treatment in Graves' disease: relationship to HLA-DR3, thyroid stimulating antibodies (TSAB), T3 suppressibility, and free T4. Frontiers in Thyroidology. 2:1107-1109, 1986.

back to top

Last Updated April 21, 2011